News

Neuroscientist Dr. Gregory Petsko has been appointed the new director of the Helen and Robert Appel Alzheimer's Disease Research Institute at Weill Cornell Medical College. We sat down with Dr. Petsko to learn about his new role, how he envisions the institute leading the charge in Alzheimer's research, and why he believes Alzheimer's disease is a looming national catastrophe.

A common pattern of low brain activity marks patients with traumatic brain injuries, no matter how they were hurt, pointing to a new therapeutic target.

Dr. Laurie H. Glimcher, dean of Weill Cornell Medical College, speaks with Dr. Hazel Szeto, professor of pharmacology. Dr. Szeto's research focuses on mitochondria, the cells' powerhouse. A peptide Dr. Szeto created with a colleague has shown promise in treating what she calls "brownout diseases" -- Alzheimer's, heart failure and diabetes among them -- in which this "power plant" doesn't function properly. In 2006, Dr. Szeto founded the biopharmaceutical company Stealth Peptides. Its first drug candidate, Bendavia, is in clinical trials.

Awards, honors, prizes and achievements for the week of April 4 - April 11.

Nearly 40 students exhibited their extracurricular research -- basic science, clinical or health care policy and research investigations that spanned those disciplines -- to their peers, faculty and other investigators during Medical Student Research Day last month.

Research reveals a new genetic route to megalencephaly, or MEG, a growth and development disorder in which the brain is abnormally large.

Gene therapy cures cardiac disease in mice with Friedreich's ataxia, a fatal muscle disorder that usually strikes teenagers.

Dr. Adam Stracher, associate professor of clinical medicine at Weill Cornell Medical College, has been appointed assistant dean of clinical affairs.

Awards, honors, prizes and achievements for the week of March 28-April 4.

Weill Cornell Medical College and drug maker UCB have teamed up to translate innovative Weill Cornell-led research in bone disorders, metabolic disease and genetics into next-generation treatments.

Ty Louis Campbell, 5, suffered from a rare brain tumor and passed away in 2012. In his honor, Ty's parents have endowed a fellowship at The Children's Brain Tumor Project to preserve and study tumor tissue from especially rare types of pediatric cancer.

Vascular surgeons are investigating the use of custom-designed stent grafts to treat thoracoabdominal aortic aneurysms.

Dr. Greg Petsko is named a Phi Beta Kappa Visiting Scholar and other awards, honors, prizes and achievements for the week of March 21 - March 28.

A new animal model developed at Weill Cornell may help investigators develop therapies for anemia of inflammation.

The 104 M.D. and Ph.D. students in the Class of 2014 learned where they will be doing their residency training -- the next three to seven years of their medical careers -- during national Match Day on March 21.

A gene previously unassociated with breast cancer plays a pivotal role in the growth and progression of the triple negative form of the disease, a particularly deadly strain that often has few treatment options.

Awards, honors, prizes and achievements for the week of March 14 - March 21.

By producing proteins that nurture cancer, blood vessel cells can turn a slow-growing malignancy into an aggressive disease that can spread and resist treatment.

Weill Cornell scientists will study the biology of the only set of identical twins who've ever left the Earth's atmosphere to see if space travel leaves a genetic fingerprint.